thumbnail image

 

seek and you will find

  • Home
  • Technology
  • Products 
    • Products Overview
    • SeekInCare
    • SeekInCure
    • SeekInClarity
    • OncoSeek
    • LeukoPrint
  • Publication
  • Newsroom
  • Get in Touch
  • …  
    • Home
    • Technology
    • Products 
      • Products Overview
      • SeekInCare
      • SeekInCure
      • SeekInClarity
      • OncoSeek
      • LeukoPrint
    • Publication
    • Newsroom
    • Get in Touch

     

    seek and you will find

    • Home
    • Technology
    • Products 
      • Products Overview
      • SeekInCare
      • SeekInCure
      • SeekInClarity
      • OncoSeek
      • LeukoPrint
    • Publication
    • Newsroom
    • Get in Touch
    • …  
      • Home
      • Technology
      • Products 
        • Products Overview
        • SeekInCare
        • SeekInCure
        • SeekInClarity
        • OncoSeek
        • LeukoPrint
      • Publication
      • Newsroom
      • Get in Touch
      • LeukoPrint®

        The first-in-class leukemia sWGS CNA test

        By evaluating the copy number aberration (CNA) in bone marrow cells and/or circulating cell free DNA (cfDNA) via shallow whole genome sequencing (sWGS), in conjunction with conventional cytogenetics, LeukoPrint® makes leukemia diagnosis, molecular subtyping, prognostic stratification and treatment responds monitoring more precise and comprehensive.

      • Without culturing cells in vitro

        High sensitivity and low failure rate

        Automatic readout system

      • An example of CNA profiling of LeukoPrint® reveals abnormal karyotype at molecular level

         

        LeukoPrint®                                                                                       Karyotyping

        Specifications

        ◉ Indicated subjects:Patients with suspected or confirmed leukemia (MDS/AML/ALL/CLL/MM)

        ◉ Sample requirement:1-2ml bone marrow or 10ml blood

        ◉ Result readout:copy number aberration(CNA)

        ◉ TAT:10 work days

      •  

        How it works

        Pre-test inquiry

         

        Informed consent 

        Blood-draw

        Testing

        Analyzing + Interpretation

         

        Reporting

         

      Navigation

      Home

      Technology   

      SeekInCare

      SeeInCure

      SeekInClarity

      OncoSeek

      Publication

      Contact Us

      10320 Camino Santa Fe, Suite G

      San Diego, CA 92121

      United States

      info@seekincancer.com

      © 2023 SeekIn, Inc.

      All Rights Reserved.

      All Posts
      ×
      Cookie Use
      We use cookies to ensure a smooth browsing experience. By continuing we assume you accept the use of cookies.
      Learn More